HHS, Regeneron collaborate on coronavirus treatment

HHS said Feb. 4 it is working with Regeneron Pharmaceuticals to develop a treatment for the coronavirus. 

The agency said it will work to develop multiple monoclonal antibodies, which help block a virus from infecting human cells. 

Regeneron previously worked on a similar treatment for Ebola and MERS. 

Read the full news release here

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars